Vaccination with chimeric protein induces protection in murine model against ascariasis

Vaccination with chimeric protein induces protection in murine model against ascariasis

•The construction of a chimeric protein leads to enhanced immune protection against Ascaris infection.•Vaccination with chimeric protein induced greater than 70% reduction in larval load after challenge.•Vaccine protection is associated with IgG response and reduced lung inflammation compared to con...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 39; no. 2; pp. 394 - 401
Main Authors: de Castro, Joseane C., de Almeida, Laila V., Cardoso, Mariana Santos, Oliveira, Fabricio M. Silva, Nogueira, Denise S., Reis-Cunha, João Luis, Magalhaes, Luisa M.D., Zhan, Bin, Bottazzi, Maria Elena, Hotez, Peter J., Bueno, Lilian L., Bartholomeu, Daniella Castanheira, Fujiwara, Ricardo T.
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 08-01-2021
Elsevier Limited
Subjects:
Animal models
Animals
Antigens
Antigens, Helminth
Ascariasis - prevention & control
Ascaris
Ascaris sp
B cell epitopes
Chimeric antigens
Deoxyribonucleic acid
Disease Models, Animal
DNA
Epitopes
Female
IgG response
Immunization
Immunoglobulin G
Infections
Inflammation
Lipid A
Lipids
Lungs
Lymphocytes B
Mice
Mice, Inbred BALB C
Monophosphoryl lipid A
Parasites
Peptides
Proteins
Recombinant Fusion Proteins - genetics
Reduction
Vaccination
Vaccine development
Vaccines
Zoonoses
Brazil
United States > US
B cell epitopes
Chimeric antigens
Ascaris sp
Antigens
IgG response
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The construction of a chimeric protein leads to enhanced immune protection against Ascaris infection.•Vaccination with chimeric protein induced greater than 70% reduction in larval load after challenge.•Vaccine protection is associated with IgG response and reduced lung inflammation compared to controls. An estimated 400 million people are infected by parasites of the genus Ascaris and the existing control measures are inefficient. Vaccine development using B cell antigens is a promising strategy for increased protection against this parasite. The present study aimed at developing a chimeric protein capable of conferring protection against infection by Ascaris sp. For this purpose, we performed B-cell epitope predictions on previously described vaccine candidate proteins from Ascaris suum and the corresponding peptides were used to construct a chimeric protein. Female BALB / c mice were immunized subcutaneously in three doses at 10 day intervals with a vaccine formulation comprised of the chimeric protein together with monophosphoryl lipid A (MPLA). Control groups included protein alone, MPLA, or PBS. After challenge infection, animals vaccinated with chimeric protein plus MPLA showed a reduction of 73.54% of larval load in the lung compared to control group animals. Animals immunized with chimeric protein plus MPLA also display higher IgG response and a reduction in lung inflammation. Our study highlights how chimeric proteins containing more than one B cell epitope can enhance immune protection against helminthic infection and offer new approaches to the development of Ascaris vaccines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2020.11.046